Highly pathogenic strains of Naegleriafowleri activate the alternative complement pathway but are resistant to lysis. In contrast, weakly pathogenic and nonpathogenic Naegleria spp. activate the complement pathway and are readily lysed. The present study was undertaken to determine whether surface components on amoebae accounted for resistance to complement lysis. Enzymatic removal of surface components from highly pathogenic N. fowleri with phosphatidylinositol-specific phospholipase C or with endoglycosidase H increased the susceptibility of these amoebae to complement-mediated lysis. Similar treatment of nonpathogenic amoebae had no effect on susceptibility to complement. Tunicamycin treatment of highly and weakly pathogenic N.
fowleri increased susceptibility to lysis by complement in a dose-related manner. Tunicamycin treatment did not alter the susceptibility of nonpathogenic amoebae to complement. Proteins of 234 and 47 kDa were detected in supernatant fluid from phosphatidylinositol-specific phospholipase C-treated highly pathogenic amoebae but not in supernatant fluid from phosphatidylinositol-specific phospholipase C-treated weakly pathogenic amoebae. Electrophoretic analysis of iodinated surface proteins of highly pathogenic N. fowleri revealed species of 89, 60, 44, and 28 kDa. Western immunoblots of lysates from surface-iodinated amoebae were stained with biotinylated concanavalin A or biotinylated Ulex europaeus agglutinin I. Surface proteins, identified in highly pathogenic amoebae by iodination, were shown to be glycoproteins by lectin analysis specific for the detection of mannose and fucose residues.
The genus Naegleria is composed of a distinct group of amoeboflagellates that include nonpathogenic species and species with pathogenic potential. One species, Naegleria fowleri, is the causative agent of primary amoebic meningoencephalitis, a fatal disease of the central nervous system in humans and in experiment animals (3, 5, 6) . The pathogenesis of this disease is poorly understood. Both weakly pathogenic and highly pathogenic strains of N. fowleri are known to exist. The ability to survive and grow at temperatures of 37°C and above does not appear to be a determinative factor in pathogenesis, since thermophilic nonpathogenic species such as Naegleria lovaniensis have been described (38) .
Hematogenous spread of N. fowleri amoebae has not been observed in human cases and is believed to be due to amoebicidal factors present in serum (3) . Mice infected intranasally with the amoebae develop a rapidly fatal disease resembling primary amoebic meningoencephalitis in humans. The mouse model has been used extensively to study host resistance to N. fowleri (26, 35) . Susceptibility to N. fowleri infection varies greatly among mouse species. The most susceptible mouse model of primary amoebic meningoencephalitis is the C5 complement-deficient strain A/HeCr (11) . Humoral and cell-mediated immunity are not the major lines of defense against Naegleria infections (35) . Experimental evidence suggests that complement is an important factor in host defense to infection, since complement-deficient mice or mice treated with cobra venom factor to deplete complement are more susceptible than normal mice to N. fowleri infections (12, 35) .
The pathogenicity of Naegleria amoebae in vivo corre-* Corresponding author.
lates with resistance to complement-mediated lysis in vitro (39) . Weakly pathogenic strains of N. fowleri and nonpathogenic Naegleria spp. activate the alternative complement pathway and are readily lysed by human and guinea pig complement (17, 39, 40) . In contrast, a highly pathogenic strain of N. fowleri activates the complement pathway but is resistant to lysis (39) . Thus, the ability of pathogenic amoebae to escape complement lysis may be an important virulence factor in the pathogenesis of primary amoebic meningoencephalitis. The naeglerial components that activate complement but allow highly pathogenic N. fowleri to escape complement-mediated lysis are unknown. Enzymatic removal of surface components from amoebae with trypsin or papain, but no sialidase, converts complement-resistant amoebae to complement-sensitive organisms, indicating that membrane surface proteins play a role in resistance to complement lysis (40) . A number of glycoproteins possessing glycosyl-phosphatidylinositol (GPI) anchors play a significant role in regulating complement-mediated lysis of cells (7, 13, 21, 28) . Some protozoa and helminths such as Trypanosoma cruzi and Schistosoma mansoni have on their surfaces GPI-anchored glycoproteins that regulate the complement pathway (19, 34, 36) . In the present study, we investigated the role of surface glycoproteins in resistance of highly pathogenic N. fowleri amoebae to complement-mediated lysis through the use of glycoprotein-specific inhibitors, lectin analysis, and endo-p-N-acetylglucosaminidase H (endo H) treatment. In addition, we utilized specific enzymatic treatment and surface iodination to examine and compare surface proteins of pathogenic strains of N. fowleri to characterize specific components that may play a role in the resistance of pathogenic amoebae to complement-mediated lysis.
COMPLEMENT RESISTANCE OF NAEGLERIA SPP.
MATERUILS AND METHODS
Amoebae. N. fowleri LEE (ATCC 30894), a strain that is weakly pathogenic in mice, was cultured axenically at 37°C in 75-mm2 plastic flasks (Thomas Scientific, Swedesboro, N.J.) in Cline medium, which consists of equal parts of Nelson medium and Balamuth medium (1, 4, 25) . N. fowlen LEEmpC1, a highly pathogenic strain, was obtained by serially passaging the LEE strain intranasally through B6C3F1 mice. After 4 days of exposure to the amoebae, samples of brain from infected mice containing strain LEEmp were cultured axenically at 37°C for not more than 1 month before another mouse passage. After 75 consecutive mouse passages at monthly intervals, the amoebae were cloned by serial dilution in microtiter well plates to obtain one amoeba per well. Wells containing one amoeba were grown to confluency, and serial dilutions of the cultures were continued for 20 growth cycles. The highly pathogenic strain N. fowleri LEEmp, which consisted of a homogeneous population, was termed LEEmpC1 (LEE mouse passage clone 1). The strain used in these studies has been passaged through mice a minimum of 90 times. N. gruberi EGB, a nonpathogenic soil isolate, was grown in Cline medium at 300C (37 After incubation, the supernatant fluid was harvested and the counts per minute were determined. The percent specific release of radiolabel from the amoebae was determined and used as an index of lysis (39) After incubation, the enzyme was removed and amoebae were washed twice with the phosphate-buffered saline-HBSS mixture, suspended in GVB2+, and incubated with NGPC for 1 h at 37°C. The percent specific release of radiolabel was determined by the amoebicidal assay.
Tunicamycin treatments. Log-phase cultures of both strains of pathogenic N. fowleni and nonpathogenic N. gruberi amoebae were grown in [3H]uridine-containing Cline medium in the absence or presence of 2.0 or 3.0 ,ug of tunicamycin (Sigma Chemical Co., St. Louis, Mo.) per ml for 18 h at 37 or 30°C. After incubation, amoebae were harvested and washed in HBSS to remove excess tunicamycin. Amoebae were counted, and 105 amoebae were incubated in NGPC for 1 h at 37°C. Parallel cultures of amoebae were grown in Cline medium in the absence or presence of tunicamycin for 18 h; then the drug was removed, and the amoebae were incubated in tunicamycin-free growth medium for 24 h. Amoebae were harvested as described above and incubated in NGPC for 1 h at 37°C. The percent specific release of radiolabel from the amoebae was determined.
Determination Trypan blue exclusion. The viability of amoebae after surface iodination was assessed by mixing equal volumes of amoebae with a 4% trypan blue (Sigma) solution after iodination in iodogen-coated vials. The amoebae were examined for exclusion of dye by using a hemacytometer and phasecontrast microscopy. The ratio of live to dead amoebae was determined, and the percent viability was calculated.
Biotinylated lectin analysis. Lysates of amoebae subjected to surface iodination were used also, for glycoprotein determination. Amoebic lysates (25 ,ug) were separated by SDS-PAGE, and proteins were transferred to nitrocellulose. Glycoproteins were detected by using VECTASTAIN ABC reagents (Vector Laboratories, Burlingame, Calif.). Nitrocellulose membranes were incubated in Tris-buffered saline (pH 7.5) containing 0.1% Tween-20 (Sigma) (TTBS) for 30 min. Nitrocellulose membranes were incubated for 45 min with 20 ,ug of either biotinylated concanavalin A or biotinylated Ulex europaeus agglutinin I per ml suspended in TTBS with gentle agitation. After incubation, the membranes were washed three times with Tl7BS and incubated for 30 min in horseradish peroxidase-conjugated avidin D (10 ,ug/ml). Membranes were washed as before and developed with a substrate solution containing diaminobenzidine-hydrochloric acid, hydrogen peroxide, and nickel chloride (Sigma). After development, the nitrocellulose blots were subjected to autoradiography at -70°C for 4 days.
RESULTS
Three Naeglena strains were treated with either PIPLC or endo H. An in vitro lytic assay was used to confirm that enzymatic removal of surface-associated membrane components from complement-resistant amoebae enhanced their susceptibility to complement-mediated lysis. Treatment of complement-resistant N. fowlen LEEmpC1 with PIPLC or endo H increased the susceptibility of highly pathogenic amoebae to lysis by complement. In contrast, neither enzymatic treatment had a significant effect on the susceptibility of weakly pathogenic or nonpathogenic Naeglena amoebae to the lytic effects of complement (Table 1) . Supernatant fluid from PIPLC-treated amoebae was collected and subjected to SDS-PAGE and then Western immunoblot analysis. Proteins transferred to nitrocellulose were detected with polyclonal rabbit antiserum prepared against freeze-thawed extracts of N. fowleni LEEmpC1 and peroxidase-conjugated goat anti-rabbit immunoglobulin G. Polypeptides from LEEmpC1 cleaved by PIPLC treatment (Fig. 1, lane 2) were compared with those released by PIPLC treatment from N.
fowleri LEE (Fig. 1, lane 3) . Proteins with relative molecular masses of 234 and 47 kDa were detected in supernatant fluid from PIPLC-treated LEEmpC1; these proteins were not detected in supernatant fluid from untreated LEEmpC1 amoebae or from untreated or PIPLC-treated LEE amoebae.
To assess the role of glycoproteins in resistance of N. fowleri to complement-mediated lysis, Naegleria amoebae were grown in Cline medium containing various concentrations of tunicamycin for 18 h before NGPC was added. The susceptibility of highly pathogenic N. fowleri LEEmpC1 and weakly pathogenic N. fowleri LEE amoebae to lysis by complement increased in a dose-related manner after growth in medium containing 2.0 or 3.0 pg of tunicamycin per ml. In contrast, growth of complement-sensitive, nonpathogenic N. gruberi amoebae in the presence of tunicamycin did not alter the susceptibility of the amoebae to complementmediated lysis ( 18 h resulted in less than 6% inhibition of protein synthesis in N. fowleri LEEmpC1 or LEE amoebae relative to that in untreated control amoebae. Treatment of N. fowleri amoebae with a higher concentration (4 ,ug/ml) of tunicamycin or increased incubation periods with the drug inhibited protein synthesis by 24%. In comparison, nonpathogenic N. gmbeni amoebae were more sensitive to tunicamycin treatment. A minimal inhibition of protein synthesis (13%) occurred in the presence of 3 ,ug of the drug per ml. Higher concentrations of tunicamycin were toxic to nonpathogenic Naeglena amoebae.
To determine whether the effect of tunicamycin is reversible, [3H]uridine-labeled LEEmpC1 and LEE amoebae were treated with tunicamycin for 18 h and then incubated in tunicamycin-free medium for 24 h. This resulted in an increased ability to resist complement-mediated damage relative to that of untreated control amoebae (Table 3) . Fig. 2A and B) . In contrast, an increased concentration of de novo-synthesized proteins was not detected in nonpathogenic N. gruben amoebae treated with tunicamycin (Fig. 2C) . In addition to an accumulation of proteins within the amoebae, the synthesis of several glycoproteins with relative molecular masses ranging from 18 to 73 kDa in pathogenic LEEmpC1 and LEE amoebae was decreased or altered after tunicamycin treatment (Fig. 2) pathogenic LEEmpC1 amoebae by surface iodination are glycoproteins and that different types of sugar residues are associated with the proteins. The 89-kDa surface protein was recognized by concanavalin A, suggesting that mannose residues were associated with this protein. Surface 60-and 28-kDa proteins stained with U. europaeus agglutinin I, suggesting the presence of fucose residues. The arrows in Fig.  4 indicate the bands stained by each lectin; these bands correspond to those detected by surface iodination in greater quantities in highly pathogenic LEEmpC1 amoebae.
LEEmpC1 strain of N. fowlen (Fig. 3) . These proteins were either absent or detected to a lesser extent by surface iodination in the weakly pathogenic LEE strain. Few similarities in surface-iodinated proteins from pathogenic and nonpathogenic amoebae were detected. Trypan blue exclusion and phase-contrast microscopy were used to determine whether amoebae were viable after iodination. Greater than 93% of the amoebae were viable as determined by the exclusion of dye.
To further characterize the specific nature of these surface proteins, lysates from surface-iodinated amoebae were separated by SDS-PAGE, transferred to nitrocellulose, and stained with biotinylated lectins specific for either mannose (concanavalin A) or fucose (U. europaeus agglutinin I). A comparison of duplicate immunoblots stained with the two lectins indicated that Naeglena proteins stain more intensely with concanavalin A than with U. europaeus agglutinin I (Fig.  4) . Although concanavalin A recognized a number of glycoproteins in nonpathogenic N. grubeni amoebae, the molecular masses of these glycoproteins differed from those of the glycoproteins recognized by concanavalin A in pathogenic strains of N. fowleri. Autoradiograms of the lectin-stained immunoblots indicate that three proteins identified in highly
DISCUSSION
The membrane attack complex of the complement system comprises terminal complement components C5b through C9, which damage cell surface membranes by the formation of transmembrane channels or pores within the membrane, ultimately resulting in osmotic lysis of the cell (29, 30) . A number of microorganisms and eucaryotic cells have developed mechanisms to evade complement lysis. Regulatory proteins present on the surface of cells interfere either by preventing activation of the complement pathway or by preventing lysis of the cell once complement has been activated (18, 29) .
We showed previously that enzymatic treatment to remove surface components from highly pathogenic N. fowleri amoebae with papain or trypsin, but not sialidase, increases the susceptibility of complement-resistant amoebae to complement-mediated lysis. Enzymatic treatment to remove surface polypeptides from nonpathogenic or weakly pathogenic amoebae had no effect on complement-mediated lysis, indicating that surface components of highly pathogenic amoebae play a role in preventing complement-mediated lysis (40) . To determine whether the membrane components responsible for conferring resistance to complement lysis are COMPLEMENT RESISTANCE OF NAEGLERL4 SPP. 2789 GPI-anchored proteins or glycoproteins, enzymes with specific cleavage sites were utilized. Both PIPLC, which removes GPI-anchored proteins, and endo H, which removes high-mannose residues present on glycoproteins, increased the susceptibility of resistant amoebae to complement-mediated lysis, but neither significantly effected complementmediated lysis of weakly pathogenic or nonpathogenic strains of Naeglenia spp. The increased susceptibility after PIPLC treatment of highly pathogenic Naeglena suggests that N. fowleni amoebae have in their membranes GPIanchored proteins that may play a role in regulating the complement pathway. GPI-anchored proteins that confer resistance to complement lysis include decay-accelerating factor (DAF) (8, 28) , homologous restriction factor or C8-binding protein (13) , and CD59 (7, 32) . The slight increase in susceptibility of Naeglena amoebae to complement after PIPLC treatment may be due to the fact that many GPIanchored proteins are relatively resistant to PIPLC release (9, 21, 22) . Two peptides that were cleaved by PIPLC treatment were identified by Western immunoblotting. Weakly pathogenic amoebae may have the same proteins but to a lesser extent. Increased concentrations of PIPLC enzyme or prolonged treatment with the enzyme can overcome the resistance of certain proteins to release by PIPLC. In the present study, high concentrations of PIPLC or increased treatment periods were found to be toxic to Naeglena amoebae (data not shown).
DAF, a regulatory membrane-bound glycoprotein, protects cells from lysis by autologous complement (15, 16, 23) . DAF binds to complement cleavage fragments C3b and C4b and either prevents or dissociates classical and alternative pathway C3-C5 convertase formation (15, 16, 27, 31) . DAF or a DAF-like protein does not appear to be involved in resistance of N. fowleni amoebae to complement-mediated lysis. Earlier studies in our laboratory of electrophoretic patterns of serum after incubation with amoebae demonstrated the conversion of complement components C3 and CS to C3b and C5b, respectively (40) . The generation of C3b and C5b cleavage products indicates that the complement pathway is activated beyond the point of DAF regulation and that DAF alone cannot be responsible for resistance of N. fowleri amoebae to complement lysis.
A number of complement-regulatory proteins are membrane-bound glycoproteins. To analyze the role of carbohydrate moieties on membrane glycoproteins, we used endo H, which specifically cleaves N-linked high-mannose residues of glycoproteins. Treatment of highly pathogenic LEEmpC1 amoebae with endo H increased the susceptibility of these amoebae to complement lysis. Treatment of weakly pathogenic or nonpathogenic strains of Naeglenia did not significantly alter susceptibility to complement-mediated lysis. These data indicate that the proteins involved in resistance to complement-mediated lysis are glycoproteins. Removal of N-linked carbohydrates may affect the ability of amoebae to resist lysis by altering the conformation of specific proteins or by removing a functional portion of the protein that is required for inhibition of complement-mediated lysis.
Tunicamycin, a naturally occurring antibiotic, specifically blocks the formation of N-linked protein-carbohydrate linkages and allows for an analysis of the functional role for specific carbohydrates of glycoproteins. Heterogeneous preparations of tunicamycin can significantly inhibit protein synthesis in addition to inhibiting protein glycosylation at asparagine residues (24) . Tunicamycin treatment of Naegleria amoebae for 18 h at a concentration that inhibits glycosylation but not protein synthesis increases susceptibility of both highly pathogenic and weakly pathogenic amoebae to complement lysis but has no effect on nonpathogenic N. gn*beni amoebae. These studies support the hypothesis that glycoproteins are important in the ability of pathogenic amoebae to resist complement-mediated damage. Increased susceptibility to complement lysis after tunicamycin treatment is reversible, since the amoebae completely recover their ability to resist complement damage after removal of the drug and subsequent incubation in tunicamycin-free medium. A slight increase in the ability of drug-treated amoebae to resist complement-mediated damage is detected after removal of the drug. Analysis of de novo-synthesized proteins in the presence of tunicamycin (Fig. 2) indicates an accumulation of proteins within the amoebae after an 18-h treatment with the drug. Carbohydrate residues present on proteins are known to dictate proper protein folding and configuration, which are necessary signals for secretion (10) . Glycoproteins that lack carbohydrates may aggregate in the endoplasmic reticulum with subsequent degradation, whereas other proteins may remain unaffected (14, 33) . Increased resistance to lysis after removal of the drug may indicate that tunicamycin treatment results in the accumulation of proteins within the amoebae. Removal of tunicamycin allows these proteins to become rapidly processed and shuttled to the surface of the amoebae, resulting in a net increase in the concentration of proteins on the surface of the amoebae and enabling the amoebae to more efficiently resist complement-mediated damage and lysis.
Enzymatic treatment to remove surface components increases the susceptibility of highly pathogenic amoebae to complement, whereas inhibition of protein glycosylation by tunicamycin increases the susceptibility of both highly pathogenic and weakly pathogenic strains of N. fowleni. These results indicate that glycoproteins present on both strains may play a role in protecting the amoebae from complement but that resistance may be the result of a quantitative difference in the glycoproteins expressed on the surfaces of the different strains. Such glycoproteins are absent from nonpathogenic amoebae.
To compare surface proteins on complement-resistant amoebae that may be involved in resistance to lysis, we employed surface iodination in combination with autoradiography. The use of this technique with highly pathogenic, complement-resistant amoebae revealed four proteins that were either absent or reduced in quantity in the weakly pathogenic LEE strain. Lectin staining of surface proteins determined that these unique proteins were glycoproteins. The attachment of terminal sugars is a major source of structural diversity for N-linked glycoproteins. Mannose and fucose are known to be typical sugar residues associated with glycoproteins (33) . In the present study, lectins specific for the detection of mannose and fucose were used to differentiate the carbohydrate residues associated with these surface proteins. Surface proteins detected in highly pathogenic LEEmpC1 amoebae contain the carbohydrate residues fucose and mannose. Studies are in progress to analyze these specific glycoproteins and determine their role in conferring complement resistance. Few similarities were detected between the surface proteins of pathogenic N. fowleni and those of nonpathogenic N. gruberi amoebae.
The increased susceptibility of highly pathogenic N. fowlen after tunicamycin and endo H treatment confirms the importance of N-linked surface glycoproteins in resistance of highly pathogenic LEEmpC1 amoebae to complement lysis. The 
